Jim L. Allen - 03 Sep 2024 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
03 Sep 2024
Net transactions value
+$150,000
Form type
4
Filing time
05 Sep 2024, 12:40:31 UTC
Previous filing
19 Oct 2023
Next filing
16 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $150,000 +50,000 +84% $3.00 109,661 03 Sep 2024 Direct F1
holding BCDA Common Stock 6 03 Sep 2024 See Footnote F2
holding BCDA Common Stock 6 03 Sep 2024 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Award +50,000 50,000 30 Sep 2024 Common Stock 50,000 $3.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.
F2 These shares are held in a custodial account for the benefit of a grandchild of the Reporting Person.
F3 These shares are held in a custodial account for the benefit of a grandchild of the Reporting Person.